Imricor Medical Systems, Inc. (ASX:IMR)
Australia · Delayed Price · Currency is AUD 1.900
+0.005 (0.26%)
Aug 7, 2026, 4:10 PM AEST
Imricor Medical Systems Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, Imricor Medical Systems stock has a consensus rating of "Strong Buy" and an average price target of $2.99. The average 1-year stock price forecast is 57.37% higher than the current stock price, while the lowest is $2.32 (+22.11%) and the highest is $3.39 (+78.42%).
Price Target: $2.99 (+57.37%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Imricor Medical Systems stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Apr '26 | May '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgans | Morgans | Buy Maintains $2.94 | Buy | Maintains | $2.94 | +54.74% | Jul 28, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $2.28 | Buy | Maintains | $2.28 | +20.00% | Jul 5, 2026 |
Tristan Maher Jarden No rating | Jarden | Buy Maintains $3.30 | Buy | Maintains | $3.30 | +73.68% | May 20, 2026 |
| Taylor Collison | Taylor Collison | Buy Maintains $3.45 | Buy | Maintains | $3.45 | +81.58% | May 15, 2026 |
Financial Forecast
Revenue This Year
3.51M
from 292.31K
Increased by 1,101.64%
Revenue Next Year
10.35M
from 3.51M
Increased by 194.70%
EPS This Year
-0.08
from -0.07
EPS Next Year
-0.07
from -0.08
EPS and Forward PE are based on non-GAAP adjusted numbers.